|Articles|May 2, 2021

Pharmaceutical Technology

  • Pharmaceutical Technology-05-02-2021
  • Volume 45
  • Issue 5

Determining the Best Estimate of Probability of Passing Multiple Stage Tests: Part 1–Content Uniformity

This article introduces a practical approach to determining the best estimate for probability of passing uniformity of dosage units (content uniformity) using probability vs. lot coverage charts and tables constructed using simulated probability and lot coverage (LC1) data.

Peer-Reviewed

Submitted: August 24, 2020
Accepted: October 12, 2020

Abstract

This article introduces a practical approach to determining the best estimate for probability of passing uniformity of dosage units (content uniformity) using probability vs. lot coverage charts and tables constructed using simulated probability and lot coverage (LC1) data. The best estimation concept is to demonstrate that the probability estimates, especially for those approaching 100%, are slightly different (deviated) from the exact calculated values by not more than (NMT) the statistically acceptable deviation limits.

Click here for a PDF of this article

Peer-reviewed research

Submitted: Aug. 24, 2020
Accepted: Oct. 12, 2020

About the author

Pramote Cholayudth is an industrial pharmacist with more than 40 years of experiences. He is a guest speaker on Process Validation to industrial pharmaceutical scientists organized by Thailand’s FDA. He is the founder and manager of PM Consult and can be contacted via cpramote2000@yahoo.com.

Article details

Pharmaceutical Technology
Vol. 45, No. 5
May 2021
Pages: 36-43

Citation

When referring to this article, please cite it as P. Cholayudth, “Determining the Best Estimate of Probability of Passing Multiple Stage Tests: Part 1–Content Uniformity,” Pharmaceutical Technology 45 (5) 2021.


Related to this article

Regulatory Roundup—September 2026
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Pharma Logistician Using IoT Based On Blockchain | Image Credit: ©leowolfert -stock.adobe.com
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.